Cover Image

Emerging data on SGLT2 benefits in acute coronary syndromes

Saved in:

Bibliographic Details
Main Author:	Aidin Rawshani (Author)
Format:	Book
Published:	Elsevier, 2024-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Emerging therapies for acute coronary syndromes
by: Scott M Lilly, et al.
Published: (2011)

Emergence of SGLT2 Inhibitors as Powerful Antioxidants in Human Diseases
by: Kai-Fan Tsai, et al.
Published: (2021)

SGLT-2 inhibitors in the management of acute decompensated heart failure
by: Anastasia E. Poskakalova, et al.
Published: (2024)

Mechanistic evaluation of the inhibitory effect of four SGLT-2 inhibitors on SGLT 1 and SGLT 2 using physiologically based pharmacokinetic (PBPK) modeling approaches
by: Yu Zhang, et al.
Published: (2023)

Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis
by: Zofia Wicik, et al.
Published: (2022)

Nursing care for acute coronary syndrome in an emergency care unit
by: Thábata Larissa Agostini dos Santos, et al.
Published: (2022)

Navigating the therapeutic landscape of SGLT2 inhibitors in diabetes management: exploring efficacy and emerging concerns
by: Farazul Hoda, et al.
Published: (2024)

Assessment of care quality to patient with acute coronary syndrome in an emergency service
by: Felipe Gonçalves dos Santos, et al.
Published: (2015)

Acute Coronary Syndrome after Percutaneous Coronary Intervention: State of the Problem and Clinical Practice Data
by: I. S. Egorova, et al.
Published: (2023)

The SGLT2 Inhibitor Empagliflozin Might Be a New Approach for the Prevention of Acute Kidney Injury
by: Chang Chu, et al.
Published: (2019)

Acute Coronary Syndromes
Published: (2012)

Cases of acute coronary syndrome - analysis of interventions of Emergency Medical Services Teams
by: Patryk Rzońca, et al.
Published: (2017)

Cases of acute coronary syndrome - analysis of interventions of Emergency Medical Services Teams
by: Patryk Rzońca, et al.
Published: (2017)

TETANIC CRISIS IN EMERGENCY CARDIOLOGY - DIFFICULTIES DIFFERENTIAL DIAGNOSIS OF ACUTE CORONARY SYNDROME
by: V. V. Rezvan, et al.
Published: (2016)

EARLY PRESCRIPTION OF PLATELET P2Y12 RECEPTOR INHIBITORS TO PATIENTS WITH ACUTE CORONARY SYNDROME: A BENEFIT OR A HARM?
by: Roman M. Shakhnovich
Published: (2018)

Use systems pharmacology modeling to elucidate the operating characteristics of SGLT1 and SGLT2 in renal glucose reabsorption in humans
by: Yasong eLu, et al.
Published: (2014)

The use of SGLT2 inhibitors in the treatment of cognitive disorders
by: Marta Lato, et al.
Published: (2023)

SGLT-2 inhibitors: Post infarction interventional effects
by: Pugazhenthan Thangaraju, et al.
Published: (2023)

SGLT2 inhibitors and the changing landscape for treatment of diabetes
by: Liu S, et al.
Published: (2019)

SGLT2 inhibitors: control of glycemia and nephroprotection properties
by: A. A. Volodin, et al.
Published: (2018)

SGLT2 inhibitors: suggestions from the amphibian world
by: Stefano Michelassi
Published: (2022)

SGLT2 Inhibitors and Fracture Risk in Elderly Population
by: Vishal R Tandon, et al.
Published: (2023)

Emerging Roles of Sodium Glucose Cotransporter 2 (SGLT-2) Inhibitors in Diabetic Cardiovascular Diseases: Focusing on Immunity, Inflammation and Metabolism
by: Lingxiang Xie, et al.
Published: (2022)

ANTICOAGULANTS IN ACUTE CORONARY SYNDROME
by: I. A. Latfullin, et al.
Published: (2016)

ANTICOAGULANTS IN ACUTE CORONARY SYNDROME
by: I. A. Latfullin, et al.
Published: (2016)

Coronary Artery Aneurysmal Disease and Acute Coronary Syndrome
by: Wesam Ostwani MD, et al.
Published: (2016)

CONTINUED OPTIMIZATION OF USE OF SGLT-2I FOR HF: IMPROVING PRESCRIPTION REFILLS OF SGLT2I AT UT TYLER INTERNAL MEDICINE RESIDENT CLINIC
by: Mariam Qazi, DO
Published: (2024)

Update on developments with SGLT2 inhibitors in the management of type 2 diabetes
by: Nauck MA
Published: (2014)

Emerging concepts in heart failure treatment and management: focus on SGLT2 inhibitors in heart failure with preserved ejection fraction
by: Andrea Beatriz De Lorenzi, et al.
Published: (2023)

SGLT2-Inhibitors - significant role in Heart Failure treatment
by: Karol Wielgus, et al.
Published: (2024)

Bibliometric and visual analysis of SGLT2 inhibitors in cardiovascular diseases
by: Runfang Pan, et al.
Published: (2024)

Reply to SGLT-2 inhibitors: Post-infarction interventional effects
by: Pasquale Paolisso, et al.
Published: (2023)

SGLT2-inhibitors are effective and safe in the elderly: The SOLD study
by: Maria Elena Lunati, et al.
Published: (2022)

Psoriasiform lesions as a side effect of SGLT-2 therapy
by: Jakub Krzysztof Gałązka, et al.
Published: (2023)

Emerging treatment options to improve cardiovascular outcomes in patients with acute coronary syndrome: focus on losmapimod
by: Kragholm K, et al.
Published: (2015)

ACUTE CORONARY SYNDROME DUE TO CORONARY VASOSPASM - CASE REPORT
by: S. D. Klimovskiy, et al.
Published: (2017)

Chest Pain with Acute Coronary Syndrome
by: Alisa Wray, MD
Published: (2018)

THE USE OF ENOXAPARIN IN ACUTE CORONARY SYNDROME
by: E. A. Smirnova, et al.
Published: (2017)

Acute coronary syndrome and renal dysfunction
by: F. I. Belyalov
Published: (2016)

FONDAPARINUX IN THE TREATMENT OF ACUTE CORONARY SYNDROME
by: O. O. Shakhmatova
Published: (2017)